Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 31;10(11):161.
doi: 10.3390/bios10110161.

A Rapid Immunochromatographic Method Based on a Secondary Antibody-Labelled Magnetic Nanoprobe for the Detection of Hepatitis B preS2 Surface Antigen

Affiliations

A Rapid Immunochromatographic Method Based on a Secondary Antibody-Labelled Magnetic Nanoprobe for the Detection of Hepatitis B preS2 Surface Antigen

Yangyang Cai et al. Biosensors (Basel). .

Abstract

Hepatitis B is a globally prevalent viral infectious disease caused by the hepatitis B virus (HBV). In this study, an immunochromatographic assay (ICA) for the rapid detection of hepatitis B preS2 antigen (preS2Ag) was established. The magnetic nanoparticles (MNPs) indirectly labelled with goat anti-mouse (GAM) secondary antibody were applied as a nanoprobe for free preS2 antibody (preS2Ab) capturing and signal amplification. By employing sample pre-incubation processing as well, preS2Ag-preS2Ab was sufficiently caught by the GAM-MNPs probe in 5 min. A qualitative sensitivity of 625 ng/mL was obtained by naked-eye observation within 15-20 min. A standard curve (0-5000 ng/mL) was established, with a quantitative limit of detection (LOD) of 3.6 ng/mL, based on the stability and penetrability of the magnetic signal characteristics. The proposed method for preS2Ag was rapid (~25 min, cf. ELISA ~4 h) and had a good accuracy, which was verified using an ELISA kit (relative error < 15%). Large equipment and skilled technicians were not required. The sensitivity and specificity of the developed GAM-MNPs-ICA method were 93.3% and 90% in clinical serum samples (n = 25), respectively. A good detection consistency (84%) was observed between the developed ICA method and 2 types of commercial ELISA kits, indicating that the GAM-MNPs-ICA has a potential application in large-scale screening for and point-of-care diagnosis of hepatitis B or other infectious diseases.

Keywords: hepatitis B; hepatitis B preS2 antigen; immunochromatographic assay; magnetic nanoparticles; rapid detection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration of GAM-MNPs-ICA for preS2Ag detection. (a) Preparation of the GAM-MNP probe using the EDC/NHS method. (b) Pre-incubation of preS2Ag, preS2Ab, and GAM-MNPs. (c) Structure of the test strip. (d) Judgment of the negative and positive results and qualitative and quantitative analysis methods.
Figure 2
Figure 2
Characterization of conjugated antigen. (a) UV absorption spectrum. (b) SDS-PAGE. M: Marker; 1: preS2Ag; 2: BSA; 3: preS2Ag-BSA.
Figure 3
Figure 3
Optimization of different T-line concentrations with 0, 50, 500, and 5000 ng/mL of preS2Ag. (a) Qualitative results. (b) Quantitative results. The error bars represented the standard deviation of three repeats (n = 3).
Figure 4
Figure 4
Optimization of the secondary antibody amount coupled onto the surface of MNPs. The error bars represent the standard deviation of three repeats (n = 3).
Figure 5
Figure 5
Qualitative results (ac) and quantitative results (d) for different concentrations of preS2Ab antibody in sample pre-incubation. The error bars represent the standard deviation of three repeats (n = 3).
Figure 6
Figure 6
Detection sensitivity of the GAM-MNPs-ICA for preS2Ag detection. (a) Qualitative detection results. (b) Quantitative standard curve. The error bars represent the standard deviation of three repeats (n = 3).
Figure 7
Figure 7
Quantitative results of the specificity analysis. The error bars represent the standard deviation of three repeats (n = 3).
Figure 8
Figure 8
Stability evaluation of GAM-MNPs-ICA. The error bars represent the standard deviation of three repeats (n = 3).

Similar articles

Cited by

References

    1. Hutin Y., Desai S., Bulterys M. Preventing hepatitis B virus infection: Milestones and targets. Bull. World Health Organ. 2018;96:443. doi: 10.2471/BLT.18.215210. - DOI - PMC - PubMed
    1. Luckenbaugh L., Kitrinos K.M., Delaney W.E., Hu J. Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy. J. Viral Hepat. 2015;22:561–570. doi: 10.1111/jvh.12361. - DOI - PMC - PubMed
    1. Siederdissen C.H.Z., Maasoumy B., Cornberg M. New viral biomarkers for Hepatitis B: Are we able to change practice? J. Viral Hepat. 2018;25:1226–1235. doi: 10.1111/jvh.12993. - DOI - PubMed
    1. Su I.J., Wang L.H.C., Hsieh W.C., Wu H.C., Teng C.F., Tsai H.W., Huang W. The emerging role of hepatitis B virus Pre-S2 deletion mutant proteins in HBV tumorigenesis. J. Biomed. Sci. 2014;21 doi: 10.1186/s12929-014-0098-7. - DOI - PMC - PubMed
    1. Yen T.T.C., Yang A., Chiu W.T., Li T.N., Wang L.H., Wu Y.H., Wang H.C., Chen L., Wang W.C., Huang W., et al. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability. Oncotarget. 2016;7:23346–23360. doi: 10.18632/oncotarget.8109. - DOI - PMC - PubMed

LinkOut - more resources